KEQU — Kewaunee Scientific Cashflow Statement
0.000.00%
Last trade - 00:00
- $101.66m
- $113.45m
- $219.49m
- 96
- 86
- 91
- 100
2019 April 30th | 2020 April 30th | 2021 April 30th | 2022 April 30th | 2023 April 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 1.69 | -4.62 | -3.61 | -6 | 1.36 |
Depreciation | |||||
Deferred Taxes | |||||
Non-Cash Items | 0.464 | 2.51 | 2.35 | 0.941 | 1.01 |
Other Non-Cash Items | |||||
Changes in Working Capital | -2.23 | 3.62 | -0.517 | -5.59 | -9.54 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Payable / Accrued Expenses | |||||
Change in Other Liabilities | |||||
Net Change in Other Assets & Liabilities | |||||
Cash from Operating Activities | 2.49 | 4.16 | 0.912 | -7.88 | -3.79 |
Capital Expenditures | -4.21 | -2.46 | -2.4 | -1.91 | -4.15 |
Purchase of Fixed Assets | |||||
Cash from Investing Activities | -4.21 | -2.46 | -2.4 | -1.91 | -4.15 |
Financing Cash Flow Items | -0.051 | -0.324 | -0.108 | 0 | — |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 2.33 | -7.46 | 1.98 | 11 | 14.9 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 0.198 | -5.94 | 0.516 | 1.16 | 6.92 |